Invention Grant
- Patent Title: Anti-DLL3 antibody drug conjugates
- Patent Title (中): 抗DLL3抗体药物偶联物
-
Application No.: US14807789Application Date: 2015-07-23
-
Publication No.: US09173959B1Publication Date: 2015-11-03
- Inventor: Robert A. Stull , Laura Saunders , Scott J. Dylla , Orit Foord , David Liu , Michael Torgov , Hui Shao
- Applicant: Stemcentrx, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Stemcentrx, Inc.
- Current Assignee: Stemcentrx, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Womble Carlyle Sandridge & Rice, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C12P21/08 ; A61K47/48 ; C07K16/28 ; C07K16/30 ; A61K31/5517 ; G01N33/574 ; A61K39/00
Abstract:
Pharmaceutical compositions to treat proliferative disorders are provided.
Public/Granted literature
- US20150328332A1 ANTI-DLL3 ANTIBODY DRUG CONJUGATES Public/Granted day:2015-11-19
Information query
